-transparent.png){kind=logo}
Fluorouracil (FUra) is the most active agent in advanced colorectal carcinoma, and this activity can be enhanced by various modulating agents both in vitro and in vivo. To determine whether interferon (IFN) is capable of augmenting the cytotoxic and cytokinetic effects of FUra, combinations of FUra and IFN alpha, -beta, and -gamma were tested against 2 human colon cancer cell lines in vitro. In a clonogenic assay, IFN alpha and -beta, at concentrations that produced less than 1 log cell kill, significantly increased the cytotoxic effects of FUra in both cell lines. IFN gamma also enhanced the cytotoxic effects of FUra, but unlike IFN alpha and -beta, only at the highest concentrations tested. Median effects analysis demonstrated that all 3 IFNs exhibited synergy with FUra. Combinations of IFNs were no more effective at modulating FUra activity than single agent IFN. Flow cytometric studies indicated that these effects did not correlate with cytokinetic alterations. Only the combination of FUra and IFN beta produced cytokinetic effects different from those of FUra alone. Incubation with IFN alpha or IFN gamma for 24 h resulted in only modest cytokinetic alterations, and they did not modify the effects of FUra. These results indicate that IFN is capable of increasing the cytotoxic actions of FUra and that this is separable from any cytokinetic effects produced by the interferons.
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
January 2000,
Oncology research,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
January 1983,
Cancer letters,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
May 2003,
The Journal of surgical research,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
September 1990,
Cancer research,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
October 1978,
Cancer research,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
October 2007,
International journal of colorectal disease,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
November 1993,
Cancer research,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
December 1994,
Phytomedicine : international journal of phytotherapy and phytopharmacology,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
March 2014,
Natural product communications,
S Wadler, and
R Wersto, and
V Weinberg, and
D Thompson, and
E L Schwartz
September 1983,
Proceedings of the National Academy of Sciences of the United States of America,
